Research Analysts’ Updated EPS Estimates for March 12th (ACCO, BWXT, CLBK, CLNN, FBLG, FM, GBFH, HOM.UN, LAZ, MC)

Research Analysts’ updated eps estimates for Thursday, March 12th:

Acco Brands (NYSE:ACCO) had its target price cut by Barrington Research from $6.00 to $5.00. The firm currently has an outperform rating on the stock.

TD Securities began coverage on shares of BWX Technologies (NYSE:BWXT). TD Securities issued a buy rating and a $230.00 target price on the stock.

Brean Capital began coverage on shares of Columbia Financial (NASDAQ:CLBK). They issued a neutral rating and a $19.00 price target on the stock.

Clene (NASDAQ:CLNN) had its buy rating reaffirmed by analysts at D. Boral Capital. They currently have a $23.00 target price on the stock.

FibroBiologics (NASDAQ:FBLG) had its buy rating reaffirmed by analysts at D. Boral Capital. D. Boral Capital currently has a $7.00 target price on the stock.

First Quantum Minerals (TSE:FM) was upgraded by analysts at UBS Group AG from a neutral rating to a buy rating. They currently have C$50.00 target price on the stock, up from their previous target price of C$38.00.

Brean Capital began coverage on shares of GBank Financial (NASDAQ:GBFH). They issued a buy rating on the stock.

BSR Real Estate Investment Trust (TSE:HOM.UN) was downgraded by analysts at Scotiabank from an outperform rating to a sector perform rating.

Lazard (NYSE:LAZ) had its target price reduced by UBS Group AG from $59.00 to $48.00. UBS Group AG currently has a neutral rating on the stock.

Moelis & Company (NYSE:MC) had its price target lowered by UBS Group AG from $74.00 to $59.00. The firm currently has a neutral rating on the stock.

MGIC Investment (NYSE:MTG) had its price target trimmed by UBS Group AG from $29.50 to $28.00. The firm currently has a neutral rating on the stock.

North American Construction Group (TSE:NOA) (NYSE:NOA) was downgraded by analysts at BMO Capital Markets from an outperform rating to a market perform rating. The firm currently has C$23.00 target price on the stock, down from their previous target price of C$26.00.

Netskope (NASDAQ:NTSK) had its outperform rating reiterated by analysts at Oppenheimer Holdings, Inc.. Oppenheimer Holdings, Inc. currently has a $19.00 price target on the stock, down from their previous price target of $23.00.

Orchestra BioMed (NASDAQ:OBIO) had its buy rating reissued by analysts at Chardan Capital. They currently have a $20.00 price target on the stock.

PJT Partners (NYSE:PJT) had its price target trimmed by UBS Group AG from $180.00 to $151.00. The firm currently has a neutral rating on the stock.

Radian Group (NYSE:RDN) had its price target reduced by UBS Group AG from $41.00 to $39.00. UBS Group AG currently has a neutral rating on the stock.

Brean Capital began coverage on shares of Regions Financial (NYSE:RF). They issued a neutral rating on the stock.

Brean Capital began coverage on shares of Trustmark (NASDAQ:TRMK). The firm issued a buy rating on the stock.

Brean Capital initiated coverage on shares of Travelers Companies (NYSE:TRV). Brean Capital issued a neutral rating on the stock.

Brean Capital began coverage on shares of Zions Bancorporation, N.A. (NASDAQ:ZION). They issued a neutral rating on the stock.